MAR 21, 2020 4:56 PM PDT

Identifying aggressive prostate cancer subtypes

New research published yesterday in the British Journal of Cancer from scientists at the University of East Anglia describes what makes certain prostate cancers more aggressive. The research involved the development of a test that is capable of quantifying the number of “aggressive” cells that a particular cancer has, thus predicting how quickly the cancer may metastasize.

Lead researcher Professor Colin Cooper commented: "Prostate cancer is the most common cancer in men in the UK. It usually develops slowly and the majority of cancers will not require treatment in a man's lifetime. However, doctors struggle to predict which tumors will become aggressive, making it hard to decide on treatment for many men. This means that many thousands of men are treated unnecessarily, increasing the risk of damaging side effects, including impotence from surgery."

How can you know if your prostrate cancer is aggressive? Photo: Pixabay

The authors of the study say that this development has significant implications for many prostate cancer patients, with the potential to ultimately reduce the need for unnecessary invasive treatments.

Using the Latent Process Decomposition, the test itself differentiates between aggressive forms of prostate cancer and less aggressive forms. Throughout the investigation, the test also discovered three subtypes of prostate cancer that had previously been unidentified.

Researcher Vincent Moulton, a professor from UEA's School of Computing Sciences, explained: "By applying the Latent Process Decomposition process and analyzing global prostate cancer datasets, we discovered an aggressive form of prostate cancer known as DESNT - which has the worst clinical outcomes for patients."

From analyzing the genetic expression of DESNT cells, the investigators were able to determine a positive correlation between the number of these “aggressive” cells and the progression of the disease.

Co-lead researcher Dr. Daniel Brewer concluded: "If you have a tumor that is majority DESNT you are more likely to get the metastatic disease, in other words it is more likely to spread to other parts of your body. This is a much better indication of aggressive disease. We also identified three more molecular subtypes of prostate cancer that could help doctors decide on different treatment options for patients. This research highlights the importance of using more complex approaches for the analysis of genomic data.”

Sources: British Journal of Cancer, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
NOV 12, 2020
Immunology
Anti-bodies against a sugar present in meat and dairy products can increase the risk of Colorectal Cancer
NOV 12, 2020
Anti-bodies against a sugar present in meat and dairy products can increase the risk of Colorectal Cancer
Nutrition is essential to health; what we eat in our daily diet affects our overall health condition and what diseases w ...
NOV 15, 2020
Genetics & Genomics
Novel Cancer-Driving Genes are Discovered
NOV 15, 2020
Novel Cancer-Driving Genes are Discovered
Cells have to be able to divide so new ones can replenish cells that get worn out, dysfunctional, or that accumulate dam ...
NOV 30, 2020
Cancer
Developing Handheld Pulse Lasers to Destroy Cancer Tissue
NOV 30, 2020
Developing Handheld Pulse Lasers to Destroy Cancer Tissue
Many take modern surgeons and surgical methods for granted. In the grand scheme of things, it wasn’t too long ago ...
DEC 07, 2020
Cancer
Can Cannabidiol inhibit head and neck cancer growth?
DEC 07, 2020
Can Cannabidiol inhibit head and neck cancer growth?
The usefulness of marijuana against cancer has been in question for some years now. Some are saying it has the potential ...
JAN 22, 2021
Clinical & Molecular DX
Breast Cancer's Nasty Nine Revealed
JAN 22, 2021
Breast Cancer's Nasty Nine Revealed
Calculating an individual’s risk of developing breast cancer isn’t easy. There’s a complex interplay b ...
JAN 22, 2021
Cancer
Geospacial analysis of HPV vaccination uptake
JAN 22, 2021
Geospacial analysis of HPV vaccination uptake
In an effort to better understand how human papillomavirus (HPV) vaccination varies by geography, researchers from VCU M ...
Loading Comments...